Neuroinflammation

Fu-Dong Shi^{1

2}

Affiliations

¹ Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, 300052, China. fshi@tmu.edu.cn.
² Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, 85013, USA. fshi@tmu.edu.cn.

Editorial

Fu-Dong Shi. Neurosci Bull. 2015 Dec.

. 2015 Dec;31(6):714-6.

doi: 10.1007/s12264-015-1568-y.

Fu-Dong Shi^{1

2}

¹ Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, 300052, China. fshi@tmu.edu.cn.
² Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, 85013, USA. fshi@tmu.edu.cn.

No abstract available

References

1. Fu Y, Liu Q, Anrather J, Shi FD. Immune interventions in stroke. Nat Rev Neurol. 2015;11:524–535. doi: 10.1038/nrneurol.2015.144. - DOI - PMC - PubMed
1. Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14:388–405. doi: 10.1016/S1474-4422(15)70016-5. - DOI - PMC - PubMed
1. Huang D. Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics. Neurosci Bull. 2015;31:745–754. doi: 10.1007/s12264-015-1560-6. - DOI - PMC - PubMed
1. Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, et al. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol. 2013;12:554–562. doi: 10.1016/S1474-4422(13)70076-0. - DOI - PubMed
1. Li M, Yan Y. Experimental models of neuromyelitis optica: current status, challenges and future directions. Neurosci Bull. 2015;31:735–744. doi: 10.1007/s12264-015-1552-6. - DOI - PMC - PubMed